Inventor
COELINGH BENNINK HERMAN JAN TIJMEN
NL28 patents
⚠️ This page may combine multiple inventors who share the name “COELINGH BENNINK HERMAN JAN TIJMEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PANTARHEI BIOSCIENCE BV
11 patentsUS8048869B2Nov 1, 2011
Pharmaceutical composition for use in hormone replacement therapy
PANTARHEI BIOSCIENCE BV71 citations97
US7943604B2May 17, 2011
Method of treating human skin and a skin care composition for use in such a method
PANTARHEI BIOSCIENCE BV70 citations97
US7943602B2May 17, 2011
Pharmaceutical application of 15- or 16-substituted testosterone analogues
PANTARHEI BIOSCIENCE BV62 citations94
US8026228B2Sep 27, 2011
Estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
PANTARHEI BIOSCIENCE BV24 citations92
US7871995B2Jan 18, 2011
Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
PANTARHEI BIOSCIENCE BV22 citations92
US7732430B2Jun 8, 2010
Drug delivery system comprising a tetrahydroxilated estrogen for use in hormonal contraception
PANTARHEI BIOSCIENCE BV22 citations92
US8367647B2Feb 5, 2013
Treatment of meconium aspiration syndrome with estrogens
PANTARHEI BIOSCIENCE BV19 citations90
US7923440B2Apr 12, 2011
Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein
PANTARHEI BIOSCIENCE BV17 citations83
US7723320B2May 25, 2010
Use of estrogen compounds to increase libido in women
PANTARHEI BIOSCIENCE BV17 citations83
US11819542B2Nov 21, 2023
Immunotherapeutic method for treating lung cancer by administering a polypeptide comprising an epitope of hZP3
PANTARHEI BIOSCIENCE BV0 citations52
US7968514B2Jun 28, 2011
Pharmaceutical composition for treating or preventing ovarian cancer
PANTARHEI BIOSCIENCE BV1 citations50
COELINGH BENNINK HERMAN JAN TIJMEN
7 patentsUS8071576B2Dec 6, 2011
Method of preventing or treating benign gynaecological disorders
COELINGH BENNINK HERMAN JAN TIJMEN58 citations95
US9034854B2May 19, 2015
Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
COELINGH BENNINK HERMAN JAN TIJMEN19 citations92
US8987240B2Mar 24, 2015
Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy
COELINGH BENNINK HERMAN JAN TIJMEN17 citations92
US9040509B2May 26, 2015
Method of treating human skin and a skin care composition for use in such a method
COELINGH BENNINK HERMAN JAN TIJMEN17 citations91
US8236785B2Aug 7, 2012
Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method
COELINGH BENNINK HERMAN JAN TIJMEN17 citations83
US10179107B2Jan 15, 2019
Tablet containing dehydroepiandrosterone (DHEA)
COELINGH BENNINK HERMAN JAN TIJMEN0 citations41
US9295720B2Mar 29, 2016
Immunotherapeutic method for treating prostate cancer
COELINGH BENNINK HERMAN JAN TIJMEN0 citations41
DONESTA BIOSCIENCE B V
4 patentsUS9987287B2Jun 5, 2018
Orally disintegrating solid dosage unit containing an estetrol component
DONESTA BIOSCIENCE B V21 citations93
US9884064B2Feb 6, 2018
Orally disintegrating solid dosage unit containing an estetrol component
DONESTA BIOSCIENCE B V18 citations93
US9561238B2Feb 7, 2017
Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy
DONESTA BIOSCIENCE B V21 citations93
US10844088B2Nov 24, 2020
Process for the preparation of estetrol
DONESTA BIOSCIENCE B V0 citations34
OXYTONE BIOSCIENCE B V
2 patentsUS10525099B2Jan 7, 2020
Orally disintegrating solid pharmaceutical dosage unit containing a partus control substance
OXYTONE BIOSCIENCE B V0 citations46
US10172913B2Jan 8, 2019
Orally disintegrating solid pharmaceutical dosage unit containing a partus control substance
OXYTONE BIOSCIENCE B V0 citations46